Chewing gum, a novel delivery system for Hempoil Cannabidiol (CBD) formulations in the treatment of Irritable Bowel Syndrome (IBS) patients.
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: CHANGOER, Lekhram (Axim Biotechnologies, New York, United States)
- Co-author(s): Lekhram Changoer: Axim Biotechnologies, New York, United States
Philip. A. Van Damme: Axim Biotechnologies, New York, United States
Chewing gum is a socially accepted way of delivering API’s by absorption via the oral mucosal membrane. The oral transmucosal route allows for bypassing the first passage elimination by the liver. Mastication is known to promote motility of the GI tract and improve the velocity in the middle cerebral artery of the brain with inherent The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.